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In genetic association studies, a single marker is often associated with multiple, correlated phe-
notypes (e.g., obesity and cardiovascular disease, or nicotine dependence and lung cancer). A
pervasive question is then whether that marker has independent effects on all phenotypes. In
this article, we address this question by assessing whether there is a direct genetic effect on one
phenotype that is not mediated through the other phenotypes. In particular, we investigate how
to identify and estimate such direct genetic effects on the basis of (matched) case-control data.
We discuss conditions under which such effects are identifiable from the available (matched)
case-control data. We find that direct genetic effects are sometimes estimable via standard re-
gression methods, and sometimes via a more general G-estimation method, which has previously
been proposed for random samples and unmatched case-control studies [37, 39] and is here ex-
tended to matched case-control studies. The results are used to assess whether the FTO gene
is associated with myocardial infarction other than via an effect on obesity.
1 Introduction
Associations of a genetic variant with a primary phenotype can be difficult to interpret
when one considers the likely presence of correlated phenotypes. The genetic association
may then be the indirect result of genetic effects on a correlated phenotype, which sub-
sequently affect the primary phenotype. For instance, Chanock and Hunter [5] discuss
2three genetic association studies which identified an association between a genetic varia-
tion on chromosome 15 and the risk of lung cancer, but the studies disagree on whether
the link is direct or mediated through nicotine dependence. Addressing this question may
be important to a better understanding of the underlying causal mechanism. This article
addresses the general problem of inferring the direct effect of a marker X on a trait Y
(e.g., lung cancer), controlling for a correlated trait M (e.g., nicotine dependence), which
we will refer to as a mediating variable or mediator.
Vansteelandt et al. [39] consider this problem in the context of prospective studies of
genetic association. Motivated by the frequent use of ascertained samples in those studies,
in this paper we extend the method to matched case-control studies. We show that
case-control sampling seriously complicates the identification of direct genetic effects.
Progress can be made within certain classes of statistical models and under specific no
unmeasured confounding assumptions. In particular, we find that, under very restrictive
conditions, direct effects are estimable from case-control data by using standard regression
methods, and that they are estimable under more lenient conditions by using special
G-estimation methods [37], which we here extend to matched case-control data. In this
paper, the required conditions for estimability are unambiguously expressed as conditional
independence relationships between problem variables, which we can check on a causal
diagram [8,17,25]. We illustrate the method with the aid of a motivating study, in which
we use matched case-control data to assess whether variation in the chromosomal region
of the FTO gene causally affects susceptibility to myocardial infarction other than via an
increase in body mass.
2 Motivating study
FTO is a large gene on chromosome 16, that is highly expressed in the hypothalamic
nuclei that control eating behaviour in mice [13]. The first intron of FTO harbours the
single nucleotide polymorphism (SNP) rs9939609, associated with body mass [35] and
myocardial infarction [1, 13, 14, 28, 32, 33, 41]. A simple, tentative, interpretation of the
evidence is that genetic variation represented (or reflected) by rs9939609 amplifies the
obesity-inducing effect of FTO, thereby indirectly affecting susceptibility to infarction.
However, an analysis of the data of Section 6, based on the method we propose in Section 5,
shows that the effect of rs9939609 on infarction is not entirely mediated by body mass.
This finding points to a different theory of the role of rs9939609 in the development of an
infarction.
Figure 1a shows a causal diagram representation of the problem. Causal diagrams are
reviewed in Appendix 1. In the diagram, we let GENO denote genetic variation respon-
sible for changes in risk of infarction and correlated with rs9939609. We let MI denote
occurrence or nonoccurrence of infarction. Let DEMO represent the following set of
3variables: sex, geographical area of origin and profession. Let BMI represent the body
mass index. Let BEHAV E represent frequent physical exercise and drinking habit. Ac-
cording to the diagram, the correlation between BEHAV E and MI is taken to be, in
part, induced by shared genetic or environmental factors, UNOBSERV ED. The miss-
ing UNOBSERV ED → BMI arrow represents the assumption that, conditionally on
BEHAV E and DEMO, no unobserved risk factors for obesity are associated with infarc-
tion. Application of the proposed method to the data of Section 6, under the assumptions
of Figure 1a, shows that the causal effect of GENO on MI is not entirely mediated by
BMI, in the sense that a (hypothetical) intervention that fixes the value of BMI would
not completely block the effect exerted onMI by a (hypothetical) intervention on GENO.
This finding points to new hypotheses about the role of rs9939609 in susceptibility to MI.
At the end of this paper we discuss the biological implications of this finding in the light
of recent experimental research evidence.
UNOBSERV ED
MI
BMI DEMO
BEHAV E GENO
(a)
UNOBSERV ED
MI
BMI DEMO
BEHAV E GENO
σBMI σGENO
(b)
Figure 1. (a) Causal diagram for our motivating study, (b) same diagram, augmented with
intervention indicators, as explained in Section 3.
43 Controlled direct effects
More in general, let X denote genetic variation of interest, and the binary variable Y
indicate occurrence (Y = 1) or non-occurrence (Y = 0) of the disease. Let M denote a
set of variables along the causal path from X to Y . Define the direct effect of X on Y ,
controlled for M , to be the effect exerted on Y by an intervention that changes the value
of X from some reference value x0 to x1, while keeping M fixed at some reference value,
m0 [26, 30]. To formalize this concept, we need to represent the idea of “intervention”.
This means to distinguish between the “observational” distribution of the data we are
analyzing, P∅, and the distribution, Pxm, of the data we would have obtained had we
fixed X to some value x and/or M to some value m. Following Dawid [8], we label
these different distributions by an intervention indicator σX and an intervention indicator
σM , where, for H ∈ (X,M), the symbol σH = ∅ indicates that the value H is observed
passively, and the symbol σH = h indicates that H is set to h by an intervention. Thus,
for a generic variable W , the symbol P (Y = 1 | σX = x, σM = m,W = w) denotes the
probability of occurrence of the outcome event, conditional on observing W = w, when
we forcefully set X to x and M to m. The direct effect of X on Y , controlled for M and
conditional on a generic set W of observed variables, can now be measured in terms of
the (causal conditional) relative risk
P (Y = 1 | σX = x1, σM = m0,W )
P (Y = 1 | σX = x0, σM = m0,W )
, (1)
or in terms of the (causal conditional) odds ratio
odds(Y = 1 | σX = x1, σM = m0,W )
odds(Y = 1 | σX = x0, σM = m0,W )
, (2)
where odds(Y = 1 | σX = x, σM = m,W = w) = P (Y = 1 | σX = x, σM = m,W =
w)/P (Y = 0 | σX = x, σM = m,W = w).
Because our data are generated from P∅, i.e., conditional on σX = ∅, σM = ∅, they will –
in general – be uninformative about the interventional probabilities involved in the direct
effect of interest, be it in the form (1) or in the form (2). Does this mean we can never
estimate a direct effect on the basis of observational data? Luckily, no. Estimation is
possible in special situations, under identifiability conditions studied in the next section.
As we shall see, these conditions can be expressed through the language of conditional
independence [10], extended by Dawid to accommodate intervention indicators [9]. An
important tool, in our subsequent discussion, are causal diagrams extended (augmented)
to incorporate intervention indicators in the form of additional nodes sending arrows into
their corresponding variables, as in [9]. One example is the causal diagram of Figure 1b,
which extends the diagram of Figure 1a by adding nodes to represent the intervention
indicators for variables X and M .
5UNOBSERV ED
S = 1 MI
BMI DEMO
BEHAV E GENO
σBMI σGENO
Figure 2. This diagram has been obtained from Figure 1b by adding the selection indicator
node, S = 1, as explained in Section 5. In the diagram, this node receives arrows from MI,
DEMO and BEHAV E. This represents the assumption that the probability of a generic
individual of the study cohort being sampled depends on (MI,DEMO,BEHAV E) while
being, conditional on these variables, independent of GENO. Its dependence on GENO would
violate condition (15).
4 Estimation from random population samples
Important results on the identifiability of controlled direct effects have been obtained by
Robins, Greenland, Didelez, Dawid, Geneletti and Pearl [11,26,29,30] under the assump-
tion that the population sample is random. These results are now summarized, with
the involved assumptions expressed in the form of conditional independence conditions
between problem variables.
If there exists a (possibly empty) set W of observed variables such that, conditionally on
W , there is no unobserved confounding of the relationship between (X,M) and Y , then
the direct effect of X on Y , controlling for M , is identifiable from random population
samples and estimable via standard regression of Y on X,M andW . The stated condition
is equivalent to asking that W is not a descendant of either M or X , and that the
distribution of Y given (X,M,W ) is the same, regardless of the way the values of X and
M are generated, be it observationally or by forceful intervention, formally:
W ⊥⊥ (σX , σM), (3)
Y ⊥⊥ (σX , σM) | (X,M,W ). (4)
6In fact, it follows from (4) that
P (Y = 1 | σX = x, σM = m,W ) = P (Y = 1 | X = x,M = m,W ),
where the righthand side can be obtained as the fitted value from a (logistic) regres-
sion model, and hence an estimate of the causal conditional relative risk (1) can also
be obtained. Conditions (3-4) can be checked on an augmented causal diagram by the
d-separation criterion [15,34] reviewed in Appendix 1, or the equivalent moralisation cri-
terion [22].
EXAMPLE 1: the diagram of Figure 1b contains causal paths from GENO to MI that do not
involve BMI. It makes thus sense to test for a direct effect of GENO on MI, controlling
for BMI. Conditions (3-4) for this test to be approachable via standard regression imply
the existence of a (possibly empty) set of variables W that satisfies:
W ⊥⊥ (σGENO, σBMI), (5)
MI ⊥⊥ (σGENO, σBMI) | (GENO,BMI,W ). (6)
In order to satisfy (5), the setW must not contain a member of BEHAV E. But then, be-
causeMI and σBMI are d-connected when BMI is in the conditioning set and BEHAV E
is not (in accord with the theory of Appendix 1), condition (6) will be inevitably violated,
and we conclude that, in this example, the direct effect of interest cannot be estimated by
using standard regression.
Estimation of the direct effect ofX on Y , controlled forM , from prospective observational
data, is possible under more lenient conditions than (3-4), although this will occasionally
require standard regression to be abandoned in favour of the more general method of G–
computation [30]. These more lenient conditions require that there be a (possibly empty)
set W of non-causal successors of X such that, conditional on W , there is no confounding
between Y and X , and a (possibly empty) set Z of non-causal successors of M such that,
conditional on (X,Z,W ), there is no confounding between Y and M . All this is formally
expressed by the following conditions:
W⊥⊥ σX , (7)
Z⊥⊥ σM , (8)
Y⊥⊥ σX | (X,W ), (9)
Y⊥⊥ σM | (X,M,Z,W ), (10)
which are similar to those given in [11]. Various authors have discussed G-computation [11,
23, 26, 29, 30, 36] or G-estimation [20, 37, 39] of controlled direct effects from a random
population sample in such settings. These authors use assumptions (7)-(10), although
they sometimes adopt a different ”language” to express them.
7EXAMPLE 2: with reference to the causal diagram of Figure 1b, if we specify W ≡ DEMO and
Z ≡ BEHAV E, then conditions (7)-(10) can be written as:
DEMO ⊥⊥ σGENO, (11)
BEHAV E ⊥⊥ σBMI , (12)
MI ⊥⊥ σGENO | (DEMO,GENO), (13)
MI ⊥⊥ σBMI | (GENO,BMI,BEHAV E,DEMO), (14)
Conditions (11)-(12) are satisfied because neither DEMO is a descendant of GENO, nor
BEHAV E a descendant of BMI. Condition (13) is satisfied because MI and σGENO are
d-separated in Figure 1b when DEMO is in the conditioning set. Finally, condition (14) is
satisfied because, as shown in Appendix 1, nodesMI and σBMI are d-separated in Figure
1b if BMI and BEHAV E are in the conditioning set. We conclude that the direct effect
of GENO on MI, controlling for BMI, is estimable by G-computation from prospective
observational data, under the assumptions of Figure 1b.
Conditions (7)-(10) do not prevent Z from being a descendant ofX , in which case the con-
ditioning on Z will – in a general prospective study – create a spurious association between
X and Y , even in absence of the direct effect we wish to assess [6, 24]. This ”collider-
stratification bias” will prevent standard regression, but not necessarily G-computation
or G-estimation, from correctly estimating the direct effect of X on Y , controlling for M ,
as shown in [39].
5 Estimation from matched case-control studies
Let us now shift attention to the estimation of controlled direct effects in the context of
a retrospective design. This is, even under the general conditions (7)-(10), a complicated
task, one reason being the possible (”exposure-induced mediator-outcome”) confounding
induced by statistical dependence between Z and σX (quite possible under (7)-(10)). The
literature on estimating controlled direct effects from retrospective designs in presence
of this type of confounding is, to the best of our knowledge, very limited so far. G-
estimation approaches to this problem in the context of unmatched case-control studies
have been suggested by Vansteelandt in [37] and [38]. The latter paper uses G-estimation
in combination with logistic regression. In this section, we shall present an approach to
the problem that works with matched case-control studies.
We start by including in the causal diagram a special node S, called the selection indi-
cator, to account for the non-random sampling involved in case-control studies. This is
exemplified in Figure 2b. The value S = 1 indicates that the individual has been selected
from the underlying study cohort for inclusion in the study, as in [16, 19]. Implicit in a
case-control study is the fact that the selection event, S, depends on the outcome, Y , and
this is why we have the Y → S arrow in the diagram. Data analysis is (by tautology)
8performed conditional on S = 1. Suppose that the usual ”rare disease assumption” is
valid, and that the “collapsibility” condition
X⊥⊥S | (Y,M,W ), (15)
is satisfied, which makes sure the conditional odds ratio odds(Y = 1 | X = x,M = m,W )
is not affected by the retrospective sampling [12,40]. In those situations where the above
condition is satisfied together with (3)-(4), a standard regression approach to the case-
control study will work (conditional logistic regression being one option when hevcase-
control study is matched). In the following, we are concerned with the more difficult
situation of a matched case-control study where condition (15), but not (3)-(4), hold.
Hence suppose that cases and controls have been 1-to-1 matched with respect to a set
W of variables that satisfies conditions (7)-(10). Let the W -matched pairs be indexed by
i (with i = 1, . . . , n) and let the generic notation G(ij) denote the value of a variable of
interest, G, for the jth member of pair i. Assume the event Y = 1 is rare (which is often
a main motivation for the choice of a retrospective design), and that the following model
is true:
E(Y | σX = x, σM = m,W,Z)
E(Y | σX = 0, σM = 0,W, Z)
= exp(ψx+ γm), (16)
where expectations E(.) refer to the population distribution. Then we show in Appendix
2 that the data will approximately satisfy:
E∗
{
(X(i1) −X(i0)) exp(−ψX(i1) − γM (i1))
}
= 0, (17)
where the expectation E∗(.) refers to the observed data distribution under retrospective
sampling. The idea is then to fit the logistic regression model:
logit P (Y (ij) = 1 | X(ij) = x, Z(ij) = z,M (ij) = m) = α + δx+ βz + ηm+ b(i),
where b(i) is a mean zero random effect, which expresses the contribution for matched
pair i. A maximum likelihood estimate of the remaining parameters, (α, δ, β, η), can be
obtained via conditional logistic regression, for example by using the CLOGIT procedure
in R. Under the ”no confounding” conditions (8) and (10), the estimate of η, denoted by
ηˆ, encodes the conditional causal effect of M on Y , represented in Equation (16) by the
symbol γ. Equation (17) then justifies the use of the following conditional score equation:
0 =
n∑
i=1
(x(i1) − x(i0)) exp
(
−ψx(i1) − ηˆm(i1)
)
(18)
for estimating the direct effect of interest, which is encoded by ψ. An estimator for the
variance of ψˆ is derived in the last paragraph of Appendix 2.
9EXAMPLE 3: it is easy to show, along the lines of Example 2, that, for W ≡ DEMO and
Z ≡ BEHAV E, the causal diagram of Figure 2 satisfies conditions (7)-(10) forW ≡ DEMO
and Z ≡ BEHAV E, and the collapsibility condition GENO⊥⊥S | (MI,BMI,DEMO), as
well. Because of the above considerations, and because early infarction is a rare disease,
we conclude that the direct effect of GENO on MI, controlling for BMI, is estimable by
G-computation from matched case-control data, under the assumptions of Figure 2.
6 Back to our motivating study
Within an Italian study in the genetics of infarction [2], cases were ascertained on the
basis of hospitalization for acute myocardial infarction between ages 40 and 45, during
the 1996 – 2002 period. This study involves the variables represented in Figures 1 and
2, and which we continue to denote through the symbols introduced in Section 2. The
controls were selected by matching them to the cases over sex, geographical area of origin
and profession (DEMO).
Our aim here is to estimate, on the basis of the study data, the effect of genetic variation
reflected by rs9939609 (GENO) on risk of early infarction (MI), controlling for body
mass (BMI). We work under the assumptions represented in the diagram of Figure
2, which appear legitimate, especially when one considers the narrow range of ages at
infarction represented in our sample of cases. Under such assumptions, we have already
seen in Example 3 that the direct effect of interest is estimable by using the algorithm
described in the previous section.
The distribution of the rs9939609 genotype in sample cases and controls is summarized in
Table 1. No major departure from Hardy-Weinberg equilibrium in controls was detected.
number of copies of the
major rs9939609 allele controls cases
0 305 380
1 889 921
2 644 537
Table 1. Distribution of the rs9939609 genotype in sample cases and controls.
Table 2 summarizes results from the fitting of a conditional logistic model for the de-
pendence of occurrence of early myocardial infarction on wild-type rs9939609 homozygos-
ity, without any adjustment for other variables in the model (except, of course, for the
matching variables). This yielded an estimate of 0.76 for the total effect of rs9939609 rare
homozygosity on infarction, on an odds ratio scale, which is significantly different from
10
OR p-value 95% confidence interval
rs9939609 wild-type homozygosity? 0.76 0.0001 0.65 - 0.87
Table 2. Results from the fitting of a conditional logistic model for the dependence of
occurrence of early myocardial infarction on rare rs9939609 homozygosity, without any
adjustment for other variables in the model. This produces an estimate of the total effect of
the rs9939609 rare homozygosity on susceptibility to early myocardial infarction, on an odds
ratio of disease scale, reported in the OR column of the table.
OR p-value 95% confidence interval
rs9939609 wild-type homozygosity? 0.81 0.007 0.7 - 0.94
body mass index 1.15 < 2e-16 1.12 - 1.17
Table 3. Results from the fitting of a conditional logistic model for the dependence of
occurrence of early myocardial infarction on rare rs9939609 homozygosity, adjusting for body
mass index.
the null at a 0.0001 level of significance. This can be interpreted as evidence of an “overall
protective” effect of the major rs9939609 allele.
When we further included body mass as an additional explanatory variable in the model,
we obtained the results of Table 3, where the effect of rs9939609 wild-type homozygosity
on infarction, 0.81 on an odds ratio scale, significantly departs from the null at a 0.007
level of significance. Unfortunately, because conditions (3-4) are violated by the diagram
of Figure 2, we cannot take this estimate as a valid measure of the direct effect of rs9939609
wild-type homozygosity on infarction, controlling for body mass. One problem here is,
in fact, that physical exercise and drinking are potential confounders of the association
between body mass and myocardial infarction.
Can this problem be overcome by including the BEHAV E variables – physical exercise
and drinking habit – as additional covariates in the regression model? When we did so,
the estimated effect of rs9939609 wild-type homozygosity on infarction was 0.84, which is
a significant (at a 0.02 level) departure from the null (see Table 4). Again, because the
causal diagram of Figure 2 violates conditions (3)-(4), our method does not guarantee
that the above estimate, obtained by standard regression, is a valid measure of the direct
effect of interest. One problem being that the conditioning on BEHAV E opens the
GENO → BEHAV E ← U → MI path (see Appendix 1) and, as a consequence, it
introduces a spurious, non causal, association between GENO andMI, so called collider-
stratification bias. We must accept the fact that, according to our method, no valid
estimate of the direct effect of interest can be obtained by standard regression. Luckily,
because the causal diagram of Figure 2 satisfies conditions (7-10, 15), our method tells us
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OR p-value 95% confidence interval
rs9939609 wild-type homozygosity? 0.84 0.02 0.72 - 0.98
body mass index 1.14 < 2e-16 1.11 - 1.16
occasional physical exercise? 0.61 1.41e-07 0.50 - 0.73
frequent physical exercise? 0.53 3.13e-13 0.44 - 0.63
drinking habit? 1.36 7.48e-05 1.17 - 1.59
Table 4. Results from the fitting of a conditional logistic model for the dependence of
occurrence of early myocardial infarction on rare rs9939609 homozygosity, adjusting for body
mass index, physical exercise and drinking habit.
that a valid estimate of the direct effect of rs9939609 on infarction, controlling for body
mass, can be obtained by using the G-estimation procedure of the preceding section. This
yields an estimate of 0.72, with a 95% confidence interval of (0.62, 0.84), on a relative risk
scale. This estimate differs appreciably from the estimates obtained in previous steps of
the analysis. The fact that the latter estimate refers to the relative risk scale, rather than
the odds ratio scale, does not entirely explain this difference in view of the low prevalence
of early-onset myocardial infarction.
From a substantive point of view, our finding suggests that genetic variation represented
by rs9939609 may influence heart disease via pathways different from those involved in
body mass. A biological interpretation of this finding is given at the end of the next
section.
7 Discussion
In this paper, we have started by examining conditions under which controlled direct
effects can be estimated from prospective observational data via standard regression.
When these conditions are violated, the direct effect of interest is sometimes still estimable
from a prospective study, albeit not via regression. We have examined the more general
conditions under which a controlled direct effect is estimable via G-computation, and we
have expressed them as properties of a causal diagram representation of the problem.
Then, in consideration of the increasing importance of matched case-control studies in
genetic epidemiology, we have shifted attention to this class of studies. We have proposed
an algorithm for the G–estimation of controlled direct effects from matched case-control
studies, and characterized the necessary conditions for algorithm validity in terms of
conditional independence properties of the causal diagram representation of the problem.
The proposed method is also relevant in situations where the notion of ”case” is not
the usual one. Examples are offered by the papers of Cordell and colleagues [7], and
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of Bernardinelli and colleagues [4], where genetic effects are estimated by conditioning
on parental genotypes, using data from proband-parent trios. These papers essentially
perform a matched case-control analysis via conditional logistic regression, using the case
and one or more ”pseudocontrols” derived from the untransmitted parental haplotypes.
This approach could be combined with the methods presented in this paper to assess
direct controlled genetic effects.
In the context of retrospective designs, further study is warranted of identification results
for controlled direct effects in specific model classes, as well as for so-called ”natural” direct
and indirect effects [27]. In addition, further work is needed to investigate whether direct
effect estimators can be constructed on the basis of matched case-control studies, which
are either more efficient than the estimator proposed in this paper, or less dependent on a
rare disease assumption. Finally, future work will also focus on inference under alternative
strategies for the selection of controls in a retrospective study.
We have illustrated the method with the aid of a study in the genetics of myocardial
infarction. Our analysis detected presence of a direct effect of rs9939609 on infarction,
controlling for body mass. This finding suggests that the effect of this SNP on suscepti-
bility to infarction is not totally explained in terms of a deleterious effect of FTO on body
mass. This finding points to a number of possible hypotheses. Very relevant here is re-
cent evidence that SNPs can, in general, exert an influence on the expression of relatively
distant (in terms of DNA stretch) genes. In our case, it could be that rs9939609 drives
the expression of a gene other than FTO, functionally unrelated with FTO, whose effect
on risk of infarction is not mediated by body mass. And hence the direct effect. Such
hypothesis is corroborated by biological evidence that the FTO is located in a genomic
region containing highly conserved genomic regulatory blocks which, according to a well
established theory, are likely to drive the expression of distant genes [3,21,31]. The above
considerations have useful implications with respect to possible experiments to elucidate
the mechanism. It is not unlikely that rs9939609 may simultaneously drive the expres-
sion of different, and functionally unrelated, genes. Such a multi-effect pattern could be
common. For example a recent study [18] shows that SNPs in the 9p21.3 region of DNA,
notoriously associated with susceptibility to infarction, not only control nearby genes, but
also the expression of the quite distant IFNA21 gene. Generalizing on this example, one
might conjecture that many SNPs exert their influence on disease susceptibility through
non-overlapping pathways, and that this will, in many cases, result in evidence of direct
and indirect effects that our method is able to capture.
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Appendix 1: Causal diagrams
Causal diagrams [8, 17, 25] consist of a set of nodes representing variables in the problem, and
directed arrows connecting pairs of nodes, as in Figure 1, for example. The same, elliptical,
shape is used for all nodes. In particular, no distinction is made, in terms of node shape, between
observed and unobserved variables/nodes, one reason being that this is not a distinction that
has to do with the causal structure of the system under study. The arrows represent direct
causal influence, in a sense to be made clear. A path is a sequence of distinct nodes where any
two adjacent nodes in the sequence are connected by an arrow. A directed path from a node X
to a node B is a path where all arrows connecting nodes on the path point away from A and
towards B. For example, in the graph of Figure 2, the sequence
GENO, BEHAV E, BMI, MI, UNOBSERV ED
is a path between GENO and UNOBSERV ED, but not a directed one.
If A has a directed path to B then A is an ancestor of B, and B a descendant of A. By
convention, A is both an ancestor and a descendant of A. If an arrow points from A to B, then
A is called a parent of B. In this paper, we restrict to causal diagrams which have the form of a
directed acyclic graph (DAG), that is, a directed graph where for any directed path from A to
B, node B is not a parent of A. A probability distribution over the set of nodes of the graph is
said to be Markov with respect to the graph if it can be expressed as a product of factors, where
each factor is the conditional probability of a node of the graph, given its parents in the graph.
A consecutive triple of nodes, A,B,C say, on a path is called a collider if the arrow between A
and B and the arrow between C and B both have arrowheads pointing to B. For example, in
Figure 1, node BEHAV E is a collider on the
GENO → BEHAV E ← UNOBSERVED
path. Any other consecutive triple is called a non-collider. A path between two nodes, A and
B say, is said to be blocked by a set C if either for some non-collider on the path, the middle
node is in C, or if the path contains a collider such that no descendant of the middle node of
such collider is in C. For example, in the graph of Figure 2, the path
GENO → BEHAV E → BMI →MI ← UNOBSERV ED
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is blocked by any set of nodes that contains either or both of (BEHAV E,BMI), and/or does
not contain S or MI. In particular, the path is blocked by the empty set of nodes.
For disjoint sets A,B,C of nodes in a DAG we say A is d-separated from B given C if every
path from a node in A to a node in B is blocked by C. If A is not d-separated from B given C,
we say A is d-connected to B given C. For example, in the diagram of Figure 1b, nodes σBMI
and MI are d-separated given (GENO,BMI,BEHAV E,DEMO). This is because all paths
between σBMI and MI contain at least one of the following non-colliders:
(MI,BEHAV E,BMI), (UNOBSERV ED,BEHAV E,BMI),
(UNOBSERV ED,DEMO,GENO), (UNOBSERV ED,DEMO,BMI),
(MI,GENO,BMI),
all of which are blocked by virtue of the fact that BEHAV E, DEMO and GENO are in the
conditioning set. As a further example, the reader is invited to check that that σGENO and MI
are d-connected in the diagram of Figure 1b if BMI, but not GENO, is in the conditioning
set. Two sets of nodes, A and B say, that are d-separated given a third set C, are conditionally
independent, in a probabilistic sense, given C, under any distribution that is Markov with
respect to the graph. By contrast, if A and B are d-connected given C, there exists some
probability distribution which is Markov with respect to the graph, under which A and B are
not conditionally independent, given C.
Appendix 2
We now prove that, under conditions (7-10, 15), model (16) and a matched case-control sampling
regime of the kind described in Section 5, the data approximately satisfy Equation (17), which
we here repeat for the reader’s convenience:
E∗
{
(X(i1) −X(i0)) exp(−ψX(i1) − γM (i1))
}
= 0, (19)
where the expectation E∗(.) refers to the observed data distribution under retrospective sam-
pling.
Model (16) implies:
E(Y | σX = x, σM = m,W,Z)
E(Y | σX = x, σM = 0,W,Z)
= exp(γm),
from which we obtain:
E(Y | σX = x, σM = m,X = x,M = m,W,Z) exp(−γm) = E(Y | σX = x, σM = 0,W,Z),
because for a generic variable H the equality σH = h logically implies H = h; at least, this
is true under the so-called consistency assumption that setting H to h by intervention has no
effect amongst those for whom H = h is naturally observed.
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Thanks to the conditioning on X = x and M = m, we may now bring the exp(−γm) factor of
the left hand side into the expectation, and further multiply both sides of the equation by the
factor exp(−ψx), so as to obtain:
E [Y exp(−ψx− γm) | σX = x, σM = m,X = x,M = m,W,Z] =
= E [Y exp(−ψx) | σX = x, σM = 0,W,Z] .
Then, by virtue of conditions (9)- (10), respectively, we can eliminate the conditioning on
σX = x and σM = m from the left hand side of the equation, which leads to:
E {Y exp(−ψx− γm) | X = x,M = m,W,Z} = E {Y exp(−ψx) | σX = x, σM = 0,W,Z} .
where the expectation at the left hand side is taken with respect to the population distribution
(which is what the absence of the σ indicators in the conditioning part means). From the above
equation, by virtue of (16), we obtain:
E {Y exp(−ψx− γm) | X = x,M = m,W,Z} = E [Y | σX = 0, σM = 0,W,Z] . (20)
The above equality implies that, conditionally on W and Z, the random variable
Y exp(−ψX − γM)
is, in expectation under the population distribution, independent of (X,M) and therefore, in a
sample from a random population, the quantity:
(Xi − E{X}) Yi exp(−ψXi − γMi) (21)
has, conditionally on W and Z, zero mean at the true parameter values.
Recall that we are dealing with a sample from a 1-to-1 matched case-control study. For the
affected member of the ith matched set, consider the quantity:
E∗
{
X(i1) exp(−ψX(i1) − γM (i1)) | W =W (i1)
}
=
= E
{
XY exp(−ψX − γM) |W =W (i1), Y = 1
}
,
= E
{
XY exp(−ψX − γM) |W =W (i1)
}
/P (Y = 1 | W =W (i1))
where the expectations E(.) are taken with respect to the population distribution. By virtue of
the above independence property, the above equation can be rewritten as:
E
{
X |W =W (i1)
}
E
{
Y exp(−ψX(i1) − γM (i1)) |W =W (i1)
}
/P (Y = 1 | W =W (i1)).
which, in the light of (20), can be written as:
= E[X | W =W (i1)] E
[
Y | σX = 0, σM = 0,W =W
(i1)
]
/P (Y = 1 |W =W (i1)),
16
Further, note that by a similar reasoning
E∗
[
X(i0) exp(−ψX(i1) − γM (i1)) | W =W (i1)
]
= E[X | W =W (i0), Y = 0] E
[
Y exp(−ψX − γM) | W =W (i1), Y = 1
]
= E[X | W =W (i0), Y = 0] E
[
Y | σX = 0, σM = 0,W =W
(i1)
]
/P (Y = 1 | W =W (i1)).
Under a rare disease assumption, we have E[X | W,Y = 0] ≈ E[X | W ], which gives Equa-
tion (19). Quod erat demonstrandum.
In the remaining part of this Appendix, we derive an estimator for the variance of the estimate
of the parameter ψ of Equation (18). We start by defining θ ≡ (ψ, δ, γ, β) and let Ui(θ) be given
by:
Ui(θ) =


(x(i1) − x(i0)) exp
(
−ψx(i1) − ηm(i1)
)

 x
(i1) − x(i0)
m(i1) −m(i0)
z(i1) − z(i0)

 expit (−δ(x(i1) − x(i0))− η(m(i1) −m(i0))− β(z(i1) − z(i0)))

 .
Let θˆ denote the estimate of θ obtained by our method. The variance of θˆ is well approximated
in large samples by the following sandwich estimator:
1
n
IE−1
(
∂Ui(θ)
∂θ
)
Var(Ui(θ))IE
−1
(
∂Ui(θ)
∂θ
)T
, (22)
where Var(Ui(θ)) can be estimated by calculating Ui(θ), then taking the sample variance of these
contributions for all subjects, and finally evaluating at θˆ. The quantity IE (∂Ui(θ)/∂θ) can be
estimated by first calculating the gradient matrix ∂Ui(θ)/∂θ for each subject, evaluating it at
θˆ and then calculating the sample average (over all subjects) of each component of the matrix.
In this gradient matrix, the element in the jth row and lth column should be the derivative of
the jth component of Ui(θ) with respect to the lth component of θ. The first diagonal element
of the resulting matrix (22) gives the approximate variance of ψˆ.
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